´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷) : 2023-04-28
±³À°ÀÏÀÚ : 2023-04-28
±³À°Àå¼Ò : ¼¿ï, ÄÚ¿¢½º
±³À°ÁÖÁ¦ : KSN(Korea Society of Nephrology) 2023 (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3452-7265
À̸ÞÀÏ : ksn@ksn.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 31 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í ¡áȸ¿ø: »çÀü(100,000)/ÇöÀå(150,000) ¡áºñȸ¿ø: »çÀü(150,000)/ ÇöÀå(200,000) ¡áFellow,Resident,Trainee,Student,Nurse,etc: »çÀü(50,000)/ ÇöÀå(35,000) *Medical Student: ¸éÁ¦
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 28ÀÏ Auditorium 13:30~14:20 Cardiorenal Benefits of Finerenone: A New Distinctive Approach for Patient with DKD John Maesaka(NYU Long Island School of Medicine)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 08:30~09:00 Cerebral/Renal Salt Wasting: Typical Cases and Pathophysiology ±è¼öÇö(Áß¾Ó´ëÇб³ ±¤¸íº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 09:00~09:30 Urate Homeostasis and Risk of Hyperuricemia in Kidney Disease ÀÌÁ¤È¯(¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 09:30~10:00 Common Cases Referred to Nephrologists for Magnesium Disturbance ¹é¼±ÇÏ(ÇѸ²´ëÇб³ µ¿Åº¼º½Éº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 10:00~10:30 Common Cases Referred to Nephrologists for Calcium Disturbance ÇѽÂÇõ(¼¼ºê¶õ½ºº´¿ø)
ÈÞ½Ä 04¿ù 28ÀÏ Room 1 10:30~11:10 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 11:10~11:40 New Trends in the Study of Human Diseases ÀÌÇϸ°(ºÎ»ê´ëÇб³º´¿ø)
½Ä»ç 04¿ù 28ÀÏ Room 1 11:40~14:50 Lunch Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 14:50~15:20 The Clinical Trial Potentials in Asia Pacific Angela Yee-Moon Wang(Queen Mary Hospital, The University of Hong Kong)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 15:20~15:50 What Comes Next after SGLT2 Inhibitors– Emerging CKD Treatments in Clinical Development at Boehringer Ingelheim Motoko Yanagita(Kyoto University Graduate School of Medicine)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 15:50~16:20 Role of Finerenone in CKD Edwina Brown(Imperial College of London)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 1 16:20~16:50 Targeting Complement in Glomerular Diseases ¿À±¹È¯(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 08:30~09:00 Difference in CRRT Implementation around the World ÀÌÁ¤Ç¥(¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 09:00~09:30 Difference in Diagnosis and Management of GN around the World °¼®ÈÖ(¿µ³²´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 09:30~10:00 Global Nutrition Care in Kidney Disease Benjamin Beno Freedman(University of Washington)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 10:00~10:30 OncoNephrology Update: Clinical Practice Guidelines for the Management of Kidney Injury during Anticancer Drug Therapy 2022 Ryuichi Nishinakamura(Kumamoto University)
ÈÞ½Ä 04¿ù 28ÀÏ Room 3 10:30~10:40 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 10:40~11:10 Glycogen Storage Disease and Kidney Function: Translational Approach ½Å±ÙÀ¯(¼¿ï´ëÇб³)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 11:10~11:40 Cell Death in Kidney Disease ¹ÚÁöȯ(±¤ÁÖ°úÇбâ¼ú¿ø (GIST))
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 11:40~12:10 Evidence-based Application of Hemodialysis in Acute Kidney Injury ½ÅÀÇö(KAIST (Çѱ¹°úÇбâ¼ú¿ø))
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 12:10~14:40 Vascular Access for Hemodialysis: Clinical Predictors of Recurrent Cephalic Arch Stenosis and Impact of Access Flow Reduction on Patency Rate Francesco Trepiccione(University of Campania)
ÈÞ½Ä 04¿ù 28ÀÏ Room 3 14:40~14:50 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 14:50~15:20 Serum and Urine Biomarker Studies in CKD Andreas Linkermann(Technische Universitat Dresden, Germany)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 15:20~15:50 Urinary Podocyte Markers in Kidney Disease Çѽ¼®(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 15:50~16:20 Omics (GWAS) Research in CKD ±è¿¹´Ï(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 16:20~16:50 Integrated Metagenomics and Metabolomics Analysis in CKD ±èÁöÀº(°í·Á´ëÇб³ ±¸·Îº´¿ø)
ÈÞ½Ä 04¿ù 28ÀÏ Room 3 16:50~17:00 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 17:00~17:30 Cardiovascular Risk Factors and CKD Outcomes: Insight from KNOW-CKD Study Àå¹®(¿¹¹Ì´ã¿ä¾çº´¿ø Àΰø½ÅÀå½Ç)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 17:30~18:00 The Chronic Renal Insufficiency Cohort (CRIC) Study – A Landmark Study of Chronic Kidney Disease ¹ÚÁ¤Å¹(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 3 18:00~18:30 Clinical Implication of Vascular Calcification in CKD Not Receiving KRT ÀÌÇѺñ(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 08:30~09:00 Reappraisal of Peritoneal Dialysis as a Home Treatment Therapy ¼±ÀοÀ(¿¹¼öº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 09:00~09:30 Current Challenges of PD In Korea: Lessions from PDOPPS Korea ¹Ú¿äÇÑ(°Ç¾ç´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 09:30~09:55 The Utility of Remote Patient Monitoring in Patients on PD ÁöÁ¾Çö(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 09:55~10:20 Application of Machine Learning for PD Patients ÀüÁؼ®(»ï¼º¼¿ïº´¿ø)
ÈÞ½Ä 04¿ù 28ÀÏ Room 4 10:20~10:40 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 10:40~10:48 Identification of Regional, Environmental, and Ethnic Factors Related to Renal Function Decline Using the Korean Genome and Epidemiology Study Database ±è¿¹¸²(°è¸í´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 10:48~10:56 Confirmation of the Electrolyte Concentration in the Dialysate Supplied Through Central Dialysis Fluid Delivery System Á¶¹ÎÇö(°æºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 10:56~11:04 Novel Non-invasive Chronic Kidney Disease Risk Stratification Tool Derived from Retina-based Deep learning and Clinical Factors for People with Preserved Kidney Function ÃÖ¼ºÀº(CHA ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:04~11:12 Prediction of Intradialytic Hypotension Using Pre-dialysis Features – A Deep Learning Based Artificial Intelligence Model (CMC-IDH-X) ¹Ú¼®¿ì(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:12~11:20 Circulating MicroRNA as a Marker for Scrub Typhus-associated Acute Kidney Injury ¹Ú¼¼ÈÆ(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:20~11:28 Effectiveness of Heart Rate Variability Test in Predicting Intradialytic Hypotension in Chronic Hemodialysis Patients ÀÓÇüÀº(°í·Á´ëÇб³ ¾È»êº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:28~11:36 Erythropoietin Modulates Cell Cycle Arrest to Ameliorate Kidney Fibrosis Á¤¹Î¼±(¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:36~11:44 Effects of Angiotensin-converting Enzyme Inhibitors and Agiotensin Receptor Blockers on the Intrarenal Renin-angiotensin System and Ischemic Acute Renal Injury Gabriel Cara-Fuentes(University of Colorado Anschutz Medical Campus)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:44~11:52 Albuminuria and Young Age Onset Diabetes: A Nationwide Population-based Study Akihiro Tojo(Dokkyo Medical University)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 11:52~12:00 Effect of Donor and Recipient Size Mismatching on the Survival of the Transplanted Kidney in Pediatric Kidney Transplant Patients À¯º´Ã¶(¼øõÇâ´ëÇб³ ºÎ¼Ó ºÎõº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:00~12:08 Evaluation of Interobserver Agreement between Renal Pathologists in the Classification of Lupus Nephritis Using Digital Pathology Image Sets Stefano Da Sacco(Keck School of Medicine of University of Southern California)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:08~12:16 Efficacy of Mesenchymal Stem Cell (MSC)-derived Extracellular Vesicles (EVs) in Cisplatin Nephrotoxicity Using Three-dimensional Gravity-driven Two-layer Tubule-on-a-chip (3D-MOTIVE chip) Hermann Haller(Hannover University)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:16~12:24 Mendelian Randomization Analysis Reveals Causal Factors Related to Kidney Function Muh Geot Wong(The University of Sydney)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:24~12:32 Maternal Exposure to Airborne Particulate Matter during Pregnancy and Lactation induces Kidney Injury in Rat Dams and Their Male Offspring: The Role of Vitamin D in Pregnancy and Beyond Dominik Steubl(Boehringer Ingelheim)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 12:32~12:40 Kidney Disease after COVID19 Vaccination in South Korea: Multicenter Study Hermann Haller(Hannover University)
½Ä»ç 04¿ù 28ÀÏ Room 4 12:40~14:50 Lunch Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 14:50~15:20 Donor Specific HLA & Non-HLA Antibodies: Is Progress Being Made Samir Parikh(Ohio State University Wexner Medical Center)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 15:20~15:50 Practical Approach to Individualizing Immunosuppression Strategies According to Alloimmune Risk ¹èÀºÈñ(Àü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 15:50~16:20 Emerging Therapeutic Options for Chronic Active ABMR Cheuk Chun Szeto(The Chinese University of Hong Kong)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 16:20~16:50 From Causes to Care Plan: Non-Immune Mediated Late Graft Failure ¹Ú¼ö°æ(¼¿ï´ëÇб³ ÀÇ°ú´ëÇÐ ¿¹¹æÀÇÇб³½Ç)
ÈÞ½Ä 04¿ù 28ÀÏ Room 4 16:50~17:00 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 17:00~17:25 Updates on Atypical HUS and C3GN: Prevention and Management Posttransplant I-Wen Wu(Keelung Chang Gung Memorial Hospital)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 17:25~17:50 The Impact of Anti-Viral Therapy and Vaccination on Outcomes In KTRs with Covid-19 ±èÈ¿»ó(¼¿ï ¾Æ»êº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 17:50~18:15 Are Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors a Game Changer for Improving Posttransplant Outcomes? ¾çÀç¼®(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 4 18:15~18:40 New Techniques and Breakthroughs in Noninvasive Allograft Monitoring Hideki Ishida(Tokyo Women)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 08:30~09:00 New Challenges of Kidney Organoids Á¤º´ÇÏ(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 09:00~09:30 Generation of 3D Kidneys from Pluripotent Stem Cells ÀÌÁÖÈÆ(¼¿ï ¾Æ»êº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 09:30~10:00 Creation of Human Assembloids Recapitulating Epithelial-Stomal Interaction in Human Cancer Rukshana Shroff(GOSH)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 10:00~10:30 Single Cell Analysis of Human Organoid Models ½ÅÀçÀÏ(¼¼ºê¶õ½ºº´¿ø)
ÈÞ½Ä 04¿ù 28ÀÏ Room 5 10:30~10:40 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 10:40~11:10 Mechanism of Proteinuria in MCD Including Role of CD80 Yuko Shima(Wakayama Medical University)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 11:10~11:40 Mechanism Underlying Selective Albuminuria in Minimal Change Disease ¼»óÇå(Àü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 11:40~12:10 Mitochondrial Injury in Pathogenesis of Minimal Change Disease Mahboob Rahman(Case Western Reserve University)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 12:10~14:40 Generation of a Glomerular Filtration Barrier on a Glomerulus-on-a Chip Platform Á¤Âù¿µ(¼¿ï¾Æ»êº´¿ø)
ÈÞ½Ä 04¿ù 28ÀÏ Room 5 14:40~14:50 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 14:50~15:15 Diet Recommendation for Children with CKD ±è¿ëö(¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 15:15~15:40 Nutritional Approach to Deter the Progression of Pediatric CKD ÀÓÁ¤ÈÆ(Ä¥°î°æºÏ´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 15:40~16:05 Immunosuppression to Prevent CKD in Children with IgA Vasculitis °íÀºÁ¤(°¡Å縯´ëÇб³ ¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 16:05~16:30 Management of IgAN and IgAV ÀÌ»óÈ£(°µ¿°æÈñ´ëÇб³º´¿ø)
ÈÞ½Ä 04¿ù 28ÀÏ Room 5 16:30~17:00 Break ( )
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 17:00~17:25 TIMP-2/IGFBP7 for Predicting AKI Çã¹Ì³ª(°Ç±¹´ëÇб³º´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 17:25~17:50 Prediction of AKI with a Help of AI ±è±âÇ¥(ÀÎÇÏ´ëÇб³ ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 17:50~18:15 How Close the Exosome therapy is to Us? À¯ÅÂÇö(¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 04¿ù 28ÀÏ Room 5 18:15~18:40 RNAi therapeutics In AKI ±è¼¼Áß(ºÐ´ç¼¿ï´ëÇб³º´¿ø)